Portolan Capital Management, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001350290
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 117 positions · Total reported value $1.21B · Top-10 concentration 27.4% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 63.3% · 29 new · 56 cut · 27 exited
Active Share (vs S&P 500): 98.8% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -8.3% · vs SPY -10.4% · Prev Value $2.67B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -2.3% · vs SPY -4.4% · Latest Value $2.40B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2024 13F filing, Portolan Capital Management, LLC disclosed 117 equity positions with a combined reported value of $1.21B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 27.4% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q2 2024 were LNTH ($50.75M), CLS ($43.18M), SMCI ($34.77M). By sector, the heaviest allocations are Technology 33.1%, Consumer Discretionary 21.4%. Versus the prior quarter, allocation shifted toward Health Care (+2.7pp), Industrials (+2.7pp) and away from Consumer Discretionary (-0.6pp), Materials (-0.8pp).
Versus the prior quarter, Portolan Capital Management, LLC opened 29 new positions, trimmed 56 and fully exited 27, a turnover rate of 63.3% of positions. The portfolio's overlap with the prior quarter was 69% of names.
The largest new positions opened in Q2 2024 were ORN ($12.06M), RDDT ($11.89M), PHAT ($11.64M).
Of the 27 positions fully exited versus the prior quarter, the largest were RCM ($14.14M), GDS ($11.06M), RPRX ($8.76M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- ORN ORION GROUP HLDGS INC · $12.06M
- RDDT REDDIT INC · $11.89M
- PHAT PHATHOM PHARMACEUTICALS INC · $11.64M
- IESC IES HOLDINGS INC · $9.68M
- MITK MITEK SYS INC · $8.30M
- TECK TECK RESOURCES LTD · $7.61M
- MDU MDU RES GROUP INC · $6.58M
- INFN INFINERA CORP · $6.56M
Fully Exited (vs previous quarter)
- RCM R1 RCM INC · prev qtr: $14.14M
- GDS GDS HLDGS LTD · prev qtr: $11.06M
- RPRX ROYALTY PHARMA PLC · prev qtr: $8.76M
- AXTI AXT INC · prev qtr: $7.33M
- GFL GFL ENVIRONMENTAL INC · prev qtr: $6.53M
- CPG CRESCENT PT ENERGY CORP · prev qtr: $6.36M
- TTGT TECHTARGET INC · prev qtr: $5.39M
- CYRX CRYOPORT INC · prev qtr: $5.23M
Insider Transactions (Form 4)
Latest Portolan Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Portolan Capital Management, LLC is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 150 US equity positions with a combined value of $2.40B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: BOSTON, MA, United States
- SEC registration: 801-73963 (status: Approved), registered 2012-03-30
- Regulatory AUM (Form ADV): $2.02B as of 2026-04-15
- Client mix (by RAUM): registered investment companies 55%, pension and profit-sharing plans 31%
- Manages 3 private funds, of which 3 hedge funds
- Website: portolan.com
Portfolio Structure
- 150 positions · $2.40B reported value (Q3 2026)
- Top 10 holdings = 24.3% of reported value
- Largest position: VIRT (VIRTU FINL INC) at 3.3%
- Average position size: $16.02M
Sector Tilt
- Information Technology 37.1%
- Consumer Discretionary 23.8%
- Health Care 15.6%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q3 2026: 29 new, 52 added, 56 reduced, 27 exited
- 13 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
632.11K | $50.75M | 4.18% | Add | |
| 2 |
|
753.12K | $43.18M | 3.56% | Reduce | |
| 3 |
|
42.44K | $34.77M | 2.86% | Reduce | |
| 4 |
|
1.92M | $33.87M | 2.79% | Reduce | |
| 5 |
|
1.63M | $32.62M | 2.69% | Add | |
| 6 |
|
139.65K | $29.43M | 2.42% | Reduce | |
| 7 |
|
278.82K | $27.94M | 2.30% | Add | |
| 8 |
|
356.00K | $26.97M | 2.22% | Reduce | |
| 9 |
|
348.56K | $26.70M | 2.20% | Add | |
| 10 |
|
1.21M | $26.36M | 2.17% | Add | |
| 11 |
|
1.92M | $25.34M | 2.09% | Add | |
| 12 |
|
8.11M | $23.67M | 1.95% | Add | |
| 13 |
|
1.19M | $23.17M | 1.91% | Add | |
| 14 |
|
1.00M | $21.52M | 1.77% | Add | |
| 15 |
|
855.84K | $19.74M | 1.62% | Add | |
| 16 |
|
166.58K | $18.04M | 1.49% | Reduce | |
| 17 |
|
54.84K | $17.47M | 1.44% | Reduce | |
| 18 |
|
286.32K | $16.99M | 1.40% | Add | |
| 19 |
|
121.10K | $15.93M | 1.31% | Reduce | |
| 20 |
|
2.90M | $15.80M | 1.30% | Add | |
| 21 |
|
293.59K | $14.73M | 1.21% | Reduce | |
| 22 |
|
195.17K | $14.49M | 1.19% | Add | |
| 23 |
|
629.15K | $13.89M | 1.14% | Reduce | |
| 24 |
|
170.25K | $13.79M | 1.14% | Add | |
| 25 |
|
187.50K | $13.75M | 1.13% | Reduce | |
| 26 |
|
1.85M | $13.22M | 1.09% | Add | |
| 27 |
|
1.82M | $13.00M | 1.07% | Add | |
| 28 |
|
183.19K | $12.66M | 1.04% | Reduce | |
| 29 |
|
419.88K | $12.66M | 1.04% | Reduce | |
| 30 |
|
2.04M | $12.59M | 1.04% | Add | |
| 31 |
|
89.99K | $12.41M | 1.02% | Add | |
| 32 |
|
1.02M | $12.20M | 1.00% | Reduce | |
| 33 |
|
731.28K | $12.13M | 1.00% | Add | |
| 34 |
|
1.27M | $12.06M | 0.99% | New | |
| 35 |
|
23.66K | $11.93M | 0.98% | Reduce | |
| 36 |
|
186.05K | $11.89M | 0.98% | New | |
| 37 |
|
187.88K | $11.85M | 0.98% | Add | |
| 38 |
|
484.91K | $11.81M | 0.97% | Add | |
| 39 |
|
1.13M | $11.64M | 0.96% | New | |
| 40 |
|
196.49K | $11.22M | 0.92% | Add | |
| 41 |
|
61.28K | $11.16M | 0.92% | Add | |
| 42 |
|
169.03K | $11.05M | 0.91% | Reduce | |
| 43 |
|
1.37M | $10.62M | 0.88% | Reduce | |
| 44 |
|
356.84K | $10.52M | 0.87% | Reduce | |
| 45 |
|
72.11K | $10.18M | 0.84% | Add | |
| 46 |
|
441.81K | $10.10M | 0.83% | Reduce | |
| 47 |
|
267.17K | $9.93M | 0.82% | Reduce | |
| 48 |
|
69.45K | $9.68M | 0.80% | New | |
| 49 |
|
1.68M | $9.29M | 0.77% | Add | |
| 50 |
|
63.37K | $9.25M | 0.76% | Reduce | |
FAQ
What did Portolan Capital Management, LLC buy in 2024-Q2?
In its 2024-Q2 13F filing, Portolan Capital Management, LLC reported 117 equity positions worth $1.21B in aggregate; its largest disclosed positions were LNTH ($50.75M), CLS ($43.18M), SMCI ($34.77M).
How large is Portolan Capital Management, LLC's portfolio?
Portolan Capital Management, LLC reported $1.21B of long equity holdings across 117 positions as of 2024-Q2. Top-10 holdings account for 27.4% of reported value.
What is Portolan Capital Management, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.